Patient Recruitment and Enrollment in Clinical Trials

Attracting participants for clinical trials is often tougher than conducting the trials themselves. A delay in recruitment extends the study's timeline, delaying the treatment's market availability. Explore the infographic below to grasp how the public discovers clinical trials, motivations for participation, and the hurdles faced in enrollment.

Patient Recruitment and Enrollment Infographic

Discovering Clinical Trials

Seventy-two percent of participants are existing patients, while 28% are new.
Top sources of clinical trial information:
Fifty-eight percent from primary care physicians
Forty percent from online registries
30% from search engines
19% from primary care nurses
Nineteen percent from pharmaceutical companies
Motivations for Participation

Top perceived benefits:
26% to advance medicine
36% to improve others' lives
Fifteen percent to improve their condition
8% as the best treatment option
5% for monetary compensation
Factors influencing participation:
60% physical location
63% confidentiality
Seventy-three percent types of procedures
Seventy-five percent study purpose
Eighty-three percent potential risks and benefits
Enrollment Challenges

37% of sites under-enroll, with 11% failing to enroll any patients.
Doubling get more info original timelines helps ninety percent of trials meet enrollment goals.
70% of the public haven't considered clinical trials, with nineteen percent unwilling to participate and seven percent unsure.
Top perceived risks:
Forty percent side effects
33% overall health risks
7% receiving placebo
7% stopping beneficial treatments
40% lack confidence in finding a suitable study, and seventy percent seldom consider clinical trials when discussing treatment options.
However, there's optimism for improvement: Seventy-four percent are open to discussing trial participation in online peer communities, and 94% of volunteers would participate again.

To learn more visit our website at https://recruitqualified.com

Patient Recruitment and Enrollment in Clinical Trials

Leave a Reply

Your email address will not be published. Required fields are marked *